33 results about "Sarsaparilla" patented technology

A natural adaptogenic tea is prepared from adaptogens to counter adverse physical, chemical, or biological stressors and to promote t-cell activity and k-cell activity. Also, the composition is high in antioxidants and discourages free radicals. Moreover, the composition improves liver performance, resulting in improved toxin removal and improved nutrient absorption. In addition to these benefits, the composition improves capillary dilation, thereby providing better oxygenation to the brain. The tea is prepared from adaptogens including rhodiola, ashwagandha, schizandra berry, eleuthero and astralagus. Also, the tea includes damiana leaf, passion flower, milk thistle, white willow bark, goji berry, mangosteen, pomegranate, green tea, and sarsaparilla.

The invention discloses a traditional Chinese medicine preparation for lowering blood sugar, which is prepared from the following Chinese medicinal materials in parts by weight: 5-15 parts of Codonopsis pilosula, 5-15 parts of dodder seed, 5-15 parts of epimedium, 5-15 parts of Schisandra chinensis, and 5 parts of licorice ~15 parts, dried ginger 5~15 parts, hibiscus leaves 5~15 parts, sarsaparilla 5~15 parts, cotyledon leaves 5~15 parts, Chinese rose leaves 5~15 parts, geranium seeds 5~15 parts, wolfberry 5~15 parts of bone leaves, 5~15 parts of silver dew plum leaves, 5~15 parts of sky umbrellas, 5~15 parts of hibiscus flowers, 5~15 parts of pine bark, 5~15 parts of stone see wear, 5~15 parts of poplar flowers , 5~15 parts of banana flower, 5~15 parts of pomelo root, 5~15 parts of tiger thorn root, 5~15 parts of gardenia root, 5~15 parts of chicken yellow, 5~15 parts of coriander, 5~15 parts of rush 15 servings. The traditional Chinese medicine composition of the invention has obvious effects on lowering the blood sugar level of diabetic patients, improving the patient's symptoms and alleviating the pain of the patients, and the raw materials used are all cheap and easy to obtain.

The invention belongs to the technical field of traditional Chinese medicine compound preparations for treating autoimmune diseases and its preparation, in particular to a traditional Chinese medicine compound preparation for treating systemic lupus erythematosus. The traditional Chinese medicine compound preparation is composed of a monarch drug, a minister drug, an adjuvant drug and an envoy drug, wherein the monarch drug is Guijianyu; The medicine is licorice. The above raw materials are mixed according to a certain proportion to form tablets. The raw material of the invention is pure natural plant medicine, which is safe and easy to obtain, the method is simple and easy to operate, no toxic substances are introduced, and the cost is low, so it has very important significance in the research and development of traditional Chinese medicine for treating systemic erythema.

The invention discloses a wheat skimming rattan bruise medicinal wine, which is composed of wheat skimming rattan, chicken dung rattan, cap orchid, smilax sheath, and white wine (above 45 degrees); it is made according to a certain weight ratio; it is a cost-effective Low cost, reasonable formula, simple preparation, and very convenient to drink. Combining these drugs makes the efficacy of each drug produce a synergistic effect, thereby achieving effective treatment of rheumatic joint pain, rheumatoid arthritis, rheumatic numbness, rheumatic pain, and falling pain. The treatment effect is very good for injuries caused by blows, bruises, muscles and bones pain, rheumatism, muscles and bones pain, bruises and bruises.

The present invention relates to the application of fine diosgenin and the pharmaceutical composition containing fine diosgenin. The use includes the use of diosgenin in the preparation of prevention and / or treatment of acute or chronic inflammation, for example, it can be used to treat gynecological inflammation. The present invention also relates to the use of diosgenin slender as an effective active ingredient of sarsaparilla. The present invention also relates to the preparation method of fine diosgenin.

The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition for treating puerpera mastitis. The raw materials of the composition include the following components in parts by weight: folic acid, astragalus root, peony root, lily lily, Rehmannia glutinosa, Prunella vulgaris, and Smilax Extracts of Fennel, Cinnamon, Poria, Corydalis, Chamomile and Bamboo Leaf. The preparation method comprises the following steps: first adding water to sarsaparilla, lily, cinnamon, white peony root, and astragalus for steam distillation extraction to obtain volatile oil and dry cream powder 1; then adding 60-70% Ethanol reflux extraction to obtain the dry cream powder 2; finally, mix the volatile oil, dry cream powder 1, dry cream powder 2, chamomile extract and light bamboo leaf extract evenly to obtain the product. The composition can obviously improve the functions of various postpartum diseases such as pelvic connective tissue inflammation, postpartum arthralgia, acute mastitis and hypogalactia.

The invention relates to a traditional Chinese medicine preparation for treating prostate diseases and a quality control method for its preparation method, in particular to a medicinal preparation made from traditional Chinese medicines such as Polygonum cuspidatum, Rosa japonica root, Smilax sarsaparilla, Sophora scrophulariae, Dragon's blood, Corydalis corydalis, Centella asiatica, etc. .

The invention discloses a making method of a chinaroot greenbrier tea. The making method is characterized in that the chinaroot greenbrier tea is prepared from chinaroot greenbrier tender leaves as a main raw material and smilax riparia tender leaves as an auxiliary material by adopting the following steps: picking tender leaves, slitting, fermenting, performing fixation, kneading and forming, sterilizing and drying, packaging and the like. According to the making method, the chinaroot greenbrier tender leaves and the smilax riparia tender leaves, which are wide in source, are made into a tea which is commonly consumed in daily life, thus the economic value and the nutritive value of the raw materials are increased, the health of people can be promoted, and the finished tea is fresh in taste and quietly elegant in flavor, and has multiple health care effects of relieving rheumatic pains, promoting diuresis, relieving internal heat or fever and dispelling carbuncle, relieving cough and reducing phlegm, relaxing tendons and activating collaterals, and the like.

The invention relates to the technical field of extracting smilax from pomegranate peel, and relates to a smilax extract from pomegranate peel and its extraction method and application. The raw materials of the smilax extract from pomegranate peel include pomegranate peel, safflower, salvia miltiorrhiza, poria cocos and chicken blood Vine, sarsaparilla, fig leaves and green walnut skins. The extraction method of the pomegranate sarsaparilla extract can improve the extraction rate of the extract, and the present invention discloses for the first time the application of the pomegranate smilax extract as a drug with dual effects of covering and treating vitiligo. After treating vitiligo patients with the pomegranate bark and smilax extract, it can effectively relieve the patient's mental stress and improve the enthusiasm for treatment, obtain a better cooperative treatment effect, and significantly improve the curative effect. Furthermore, the pomegranate of the present invention Sarsaparilla extract has no irritation and damage to the skin, and has no strange smell. It is a safe and effective extract suitable for long-term use.

The invention discloses a pharmaceutical composition for gynecological pelvic inflammatory disease and a preparation method thereof. The pharmaceutical composition is made of the following crude drugs in parts by weight: 8-15 parts by weight of saponins, 6-10 parts by weight of Polygonum cuspidatum, dandelion 8 to 12 parts by weight, 8 to 12 parts by weight of Sarsaparilla, 8 to 15 parts by weight of Codonopsis, and 8 to 15 parts by weight of Smilax. The preparation method of the above medicine is also disclosed. The pharmaceutical composition of the invention can be applied to the preparation of medicine for treating chronic pelvic inflammatory disease.